Scientific research and publications
Computational oncology research, reproducibility work published in the European Journal of Endocrinology, and 13 peer-reviewed publications with international collaborations.
I combine scientific reasoning, statistical modeling and engineering to investigate complex problems and build analytical systems that can be examined, reproduced and used in practice.
My work combines statistical modeling, artificial intelligence, bioinformatics, data engineering, product development, and strategic consulting across biomedical, legal, financial, environmental, and institutional applications.
My trajectory has followed a consistent pattern: understand complex systems, translate them into measurable variables, and build practical solutions that improve decisions and processes.
I am a Computational Oncology researcher and Data Scientist with a multidisciplinary background spanning biotechnology, statistical modeling, bioinformatics, data engineering, artificial intelligence, and analytical product development.
My career has followed a consistent pattern: understanding complex systems, translating them into measurable variables, and building models or tools that improve decisions. This approach has taken me from experimental biotechnology and industrial process modeling to computational oncology, financial simulation, legal analytics, public-sector studies, and AI-driven products.
Today, I combine scientific research with applied data science as Co-founder and Head of AI & Data Science at Neuraxis and as a Postdoctoral Researcher at the Pelé Pequeno Príncipe Research Institute.
Pick the path closest to why you are here — research, applied data science, or consulting.
Computational oncology research, reproducibility work published in the European Journal of Endocrinology, and 13 peer-reviewed publications with international collaborations.
End-to-end data products, AI systems, and analytical platforms — from genetic-analysis workflows and environmental data products to a public finance simulator covered by the press.
Simulation models, due diligence, and decision-support systems for institutional and corporate clients, including the precatório simulator developed for OAB-PR.
Curious about the person behind the work? Beyond work →
Four complementary dimensions structure my work.
Predictive modeling, machine learning, neural networks, computer vision, classification, simulation, and applied AI.
Transcriptomics, regulatory networks, clinical genomics, immune profiling, survival analysis, and precision oncology.
Relational databases, ETL pipelines, APIs, automation, dashboards, analytical platforms, and reproducible workflows.
Financial simulation, institutional studies, business intelligence, public finance, decision-support systems, and technical consulting.
Academic credentials, scientific recognition, international memberships, and formal education reflecting key milestones in my scientific and professional trajectory.
Award certificate — MD Anderson Cancer Center
Received the Abstract Award for Outstanding Contribution at the 9th International Adrenal Cancer Symposium for research on the cross-study reconciliation of SF-1 regulatory targets in adrenocortical carcinoma.
The study addressed a scientific inconsistency that had remained unresolved for more than a decade by reconciling apparently divergent SF-1 perturbation studies and demonstrating convergence at the transcriptional and phenotypic levels.
Official MIT letter — Institute for Data, Systems, and Society
Completed the full MITx MicroMasters Program in Statistics and Data Science, covering probability, statistics, machine learning, and data analysis through graduate-level coursework and proctored capstone examinations.
The official MIT letter describes the four courses as equivalent to graduate-level MIT courses and emphasizes that they follow the same level of rigor as their residential counterparts.
Official membership letter — Sigma Xi
Elected as a Full Member of Sigma Xi, an international and multidisciplinary research honor society. Full membership is granted by nomination and recognizes noteworthy achievements in scientific research.
The official membership letter states that Full Membership is conferred upon researchers who have demonstrated noteworthy achievements in research, considering publications, research trajectory, quality of research, and scientific contributions.
Performance letter — Harvard Medical School
Completed advanced training in immuno-oncology through Harvard Medical School’s HMX Pro program, integrating immunology, tumor biology, and therapeutic approaches.
Honorable mention — Federal University of Paraná
Awarded by the Graduate Program in Microbiology, Parasitology and Pathology in recognition of the scientific production resulting from my doctoral thesis in adrenocortical carcinoma and immune-oncogenomics.
Member profile — AI for Developing Countries Forum
Active participation in international communities connecting scientific research, artificial intelligence, and translational oncology.
European Network for the Study of Adrenal Tumours — ENS@T
2025–Present
AI for Developing Countries Forum — AIFOD
2025–Present
Federal University of Paraná, 2022
Immune-oncogenomic analysis of adrenocortical carcinoma. Honorable Mention for the scientific production resulting from the thesis.
Massachusetts Institute of Technology, 2023
Probability, statistics, computation, and machine learning. Top 25%.
Federal University of Paraná, 2011
Interdisciplinary training in biological processes, engineering, mathematics, and industrial biotechnology. Top 25%.
Master’s coursework completed in Biotechnology for Sustainable Development. The research project, developed in partnership with TECPAR, focused on quantitative detection of tetanus toxoid. The degree was not completed after the Bacterial Vaccines Division was discontinued.
Institutional and media coverage of selected scientific and analytical work.
The Institute highlighted my research reconciling a long-standing methodological discrepancy in SF-1/NR5A1 target identification in adrenocortical carcinoma, work that also received an Abstract Award at the International Adrenal Cancer Symposium at MD Anderson Cancer Center.
A public-finance simulation model developed through Grand Hill for OAB-PR was featured in the press during the national debate over proposed changes to Brazil’s precatório payment framework.
As the only technical member of a joint GreenPlat–Mercedes-Benz team, I built the MVP of FleetGreen, a telemetry-based emissions product showcased at FENATRAN 2022. The product later evolved under Mercedes-Benz and received third place at the 2024 Daimler Truck Green Mover Award.
I am open to international collaboration, research partnerships, data-science projects, technical consulting, and opportunities involving applied AI, bioinformatics, and analytical product development.
I am particularly interested in projects that combine technical complexity, scientific rigor, interdisciplinary thinking, and meaningful practical impact.
Location & time zone: Curitiba, Brazil (UTC−3) — full overlap with US Eastern mornings and 3–4 hours of overlap with Central European afternoons.
Languages: fluent English — the working language of my scientific writing, conference presentations, and international collaborations; advanced French (Alliance Française); native Portuguese.
Engagement: available for remote positions as a direct hire or as an independent contractor. Consulting and B2B engagements can be arranged through Quantum Data Science. Also open to scientific collaboration.